BECKMAN HOLDINGS LIMITED

1. BECKMAN HOLDINGS LIMITED 1988-11-17 → present
2. MITBIND LIMITED 1988-10-10 → 1988-11-17

Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. About these numbers

Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.

Accounting basis

FRS 101

Reporting scope

Standalone (parent only)

Auditor

Ernst & Young LLP

Audit opinion

Unqualified (clean)

Going concern

Affirmed

“After making enquiries and considering the cash balance held and net current asset position, access to funds via further cash pool facilities or dividend income, the directors have a reasonable expectation that the company has adequate resources to continue in operation for 12 months from the date of signing of these financial statements. These considerations included the impact of the current global geo-political environment and macroeconomic inflationary pressures on the company, as well as the wider UK and Danaher Corporation group. Accordingly, the financial statements have been prepared on the going concern basis.”

Group structure

1. BECKMAN HOLDINGS LIMITED · parent
   1. Beckman Coulter Biyomedikal Urunler Sanayi ve Ticaret Limited 75.92% · Turkey · Trading Company

Significant events

• “On 13 December 2023, the intercompany loan receivable from Beckman Coulter United Kingdom Limited has been fully repaid to Beckman Holdings Limited for a total cash amount of £3,085,000 (£2,700,000 loan principal and £385,000 interest).”
• “On 18 June 2024, Beckman Holdings Limited reduced its share capital by cancelling share premium of £57,887,000 which was transferred to the profit and loss account reserve.”
• “On 19 July 2024, terms have been agreed with Beckman Coulter Inc (BCI) for Beckman Holdings Limited to purchase 26 ordinary shares of £1.00 each in the capital of the Company registered in BCI's name for an aggregate purchase price of £20,000,000 paid in cash.”
• “On 07 April 2025, Beckman Coulter Biyomedikal Urunler Sanayi ve Ticaret Limited distributed a net cash dividend to Beckman Holdings Limited (BHL) of £1,917,000 (net of £338,000 withholding tax).”

Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers

Filings

6

last 12 months

Capital events

7

last 24 months

Officers appointed

1

last 12 months

Officers resigned

2

last 12 months

Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.

• Turnover

  —

  Not reported

• Cash

  -42.2%

  £35,923,000 → £20,776,000

• Net assets

  -30.1%

  £60,649,000 → £42,407,000

• Employees

  —

  Not reported

• Operating profit

  -7.7%

  -£13,000 → -£14,000

• Profit before tax

  -88.2%

  £14,883,000 → £1,758,000

Each % is (latest − prior) ÷ |prior| for the line item as filed. The comparison is only shown when the latest and prior accounts cover broadly equal-length periods — short or long stubs (typical around incorporation or a year-end change) are suppressed rather than misrepresented. Lines a company doesn't report are omitted. About these numbers